CTCF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.262000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.006300E-02
Normal-vs-Stage2
9.440200E-02
Normal-vs-Stage3
5.606300E-02
Normal-vs-Stage4
9.915800E-01
Stage1-vs-Stage2
9.815800E-01
Stage1-vs-Stage3
1.000350E-01
Stage1-vs-Stage4
1.505230E-01
Stage2-vs-Stage3
6.673600E-02
Stage2-vs-Stage4
5.462200E-02
Stage3-vs-Stage4
7.104000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.129700E-02
Normal-vs-AfricanAmerican
3.586800E-01
Normal-vs-Asian
6.422400E-02
Caucasian-vs-AfricanAmerican
3.918200E-01
Caucasian-vs-Asian
2.057400E-01
AfricanAmerican-vs-Asian
1.657580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.162640E-01
Normal-vs-Female
7.634200E-02
Male-vs-Female
6.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.174410E-01
Normal-vs-Age(41-60Yrs)
2.063400E-01
Normal-vs-Age(61-80Yrs)
7.330300E-02
Normal-vs-Age(81-100Yrs)
2.525600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.846800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.197800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.421000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.022180E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.620400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.500300E-02
Normal-vs-Daily Drinker
6.616400E-02
Normal-vs-Weekly Drinker
3.632500E-02
Normal-vs-Occasional Drinker
3.001800E-01
Normal-vs-Social Drinker
1.167800E-01
Non Drinker-vs-Daily Drinker
9.642400E-01
Non Drinker-vs-Weekly Drinker
3.804400E-01
Non Drinker-vs-Occasional Drinker
4.604100E-02
Non Drinker-vs-Social Drinker
4.634400E-01
Daily Drinker-vs-Weekly Drinker
4.363000E-01
Daily Drinker-vs-Occasional Drinker
5.861700E-02
Daily Drinker-vs-Social Drinker
4.706400E-01
Weekly Drinker-vs-Occasional Drinker
1.544460E-02
Weekly Drinker-vs-Social Drinker
1.650980E-01
Occasional Drinker-vs-Social Drinker
2.647200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.492100E-02
Normal-vs-Grade 2
2.061600E-03
Normal-vs-Grade 3
1.696270E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.147800E-01
Grade 1-vs-Grade 3
1.694650E-01
Grade 1-vs-Grade 4
4.492100E-02
Grade 2-vs-Grade 3
4.015600E-01
Grade 2-vs-Grade 4
2.061600E-03
Grade 3-vs-Grade 4
1.696270E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.432100E-02
Normal-vs-NonDiabetic
5.290000E-02
Diabetic-vs-NonDiabetic
5.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.016300E-03
Normal-vs-NoPancreatitis
7.463700E-02
Pancreatitis-vs-NoPancreatitis
2.311000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.600400E-02
Normal-vs-N1
1.100980E-01
N0-vs-N1
8.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.557400E-01
Normal-vs-TP53-NonMutant
3.081200E-01
TP53-Mutant-vs-TP53-NonMutant
2.818000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
